SCHEMBL21249366

SCHEMBL21249366

C=C(C)C(=C)OC1(CCCCC)C2CC3CC1CC(C)(C3)C2

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL685590 0.87 TSHR (0.37) EPHX2
SCHEMBL684921 0.86 TSHR (0.39) EPHX2
SCHEMBL684912 0.86 TSHR (0.39) EPHX2
SCHEMBL685525 0.86 TSHR (0.39) EPHX2
SCHEMBL685593 0.83 TSHR (0.35) EPHX2
SCHEMBL686031 0.81 THRB (0.36) EPHX2
SCHEMBL685601 0.80 THRB (0.36) EPHX2
SCHEMBL685696 0.80 THRB (0.36) EPHX2
SCHEMBL686033 0.80 THRB (0.36) EPHX2
SCHEMBL2607835 0.77 EPHX2 (0.32) EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10377692-B2 Photoresist composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2019-08-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10377692-B2 Photoresist composition C1R, C1S, F12 EPHX2 700/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.